Home/Filings/4/0001209191-21-028105
4//SEC Filing

KANE MATTHEW R. 4

Accession 0001209191-21-028105

CIK 0001357874other

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 4:06 PM ET

Size

7.9 KB

Accession

0001209191-21-028105

Insider Transaction Report

Form 4
Period: 2021-04-21
KANE MATTHEW R.
DirectorPresident and CEO10% Owner
Transactions
  • Exercise/Conversion

    Common Stock

    2021-04-21$1.18/sh+13,422$15,8381,978,218 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2021-04-2113,4220 total
    Exercise: $1.18Exp: 2027-03-23Common Stock (13,422 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    10,841
Footnotes (2)
  • [F1]Shares are held by Chelsea Lynam Kane, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F2]The option is fully vested and exercisable.

Issuer

PRECISION BIOSCIENCES INC

CIK 0001357874

Entity typeother

Related Parties

1
  • filerCIK 0001769887

Filing Metadata

Form type
4
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 4:06 PM ET
Size
7.9 KB